Quest Diagnostics dividend history

Quest Diagnostics's dividend was $1.80 a share in fiscal 2017, up 9.1% on the year before. That was 32.0% of net income. It has raised its dividend per share every year since fiscal 2010.

Dividends, buybacks and capital spending

Dividends (TTM): $369M
Buybacks, last 3 fiscal years: $876M
Diluted share count: −1.1%; year over year
Total shareholder yield: 1.3%; dividends 1.3% + buybacks 0.0% of market value
Dividend payout ratio: 33%; of net income paid out
Sales & admin spending: 17.4%; of revenue
Days sales outstanding: 53 days; receivables vs revenue

Dividends by fiscal year

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Quest Diagnostics: dividends by fiscal year, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Dividend per share	$0.400	$0.400	$0.470	$0.810	$1.20	$1.32	$1.52	$1.65	$1.80	—	—	—	—	—	—	—	—	—
Dividend per share growth	—	0.0%	+17.5%	+72.3%	+48.1%	+10.0%	+15.2%	+8.6%	+9.1%	—	—	—	—	—	—	—	—	—
Dividends paid	75	71	65	108	185	187	212	223	247	266	286	297	309	305	314	331	353	369
Share buybacks	500	750	935	200	1,037	132	224	590	465	322	353	325	2,199	1,408	275	151	450	—
Dividends ÷ net income	10.3%	9.9%	13.8%	19.4%	21.8%	33.6%	29.9%	34.6%	32.0%	36.1%	33.3%	20.8%	15.5%	32.2%	36.8%	38.0%	35.6%	32.7%

Dividend per share is the amount declared for the fiscal year as stated in the company's filings (including any special dividend), restated for stock splits and checked against the cash dividends paid. Dividends paid and buybacks are cash amounts; the last-twelve-months column can include an extra payment when a quarter-end date moves.

Compare with peers

Labcorp dividends

Head to head: DGX vs LH

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Quest Diagnostics's SEC filings (10-K and 10-Q), retrieved October 24, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Quest Diagnostics.